Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001707685-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | PTCT | Utter Christine Marie | SVP, CAO | A - Grant | $0.00 | +13.2K | 76.3K | +21% | $0 |
| D | 2026-01-06 | 2026-01-02 | PTCT | Utter Christine Marie | SVP, CAO | A - Grant | $0.00 | +33.1K | 33.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | A | A | 13,250 | $0.00 | 76,343 | D | — | — | (F1) Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027. (F2) Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-01-02 | A | A | 33,125 | $0.00 | 33,125 | D | $76.74 · — to 2036-01-01 | 33,125 Common Stock | (F3) This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027. |